Inactive
Notice ID:75F40122R00034
Update 5/16/2022: Please see the attached solicitation questions and responses as well as an amended Attachment 4 - Pricing Worksheet. Please see the attached solicitation and attachments for details....
Update 5/16/2022: Please see the attached solicitation questions and responses as well as an amended Attachment 4 - Pricing Worksheet. Please see the attached solicitation and attachments for details. Quotations shall be submitted electronically via email to the Contract Specialist, Noah Wills at Noah.Wills@fda.hhs.gov, and the Contracting Officer, Gary Klaff at Gary.Klaff@fda.hhs.gov, by 3:00pm (Eastern) on Friday, May 27, 2022. The subject line shall read: “75F40122R00034 - mRNA-Based Vaccine Training.” Late submissions may not be evaluated. Fax submissions are not authorized. Questions/clarifications regarding this requirement shall be submitted via email to the Contract Specialist, Noah Wills at Noah.Wills@fda.hhs.gov, and the Contracting Officer, Gary Klaff at Gary.Klaff@fda.hhs.gov, by 3:00pm (Eastern) on Wednesday, May 11, 2022. FDA may not answer questions received after this date and time, and will not answer questions submitted to individuals other than the named contacts. Questions submitted by another means will not be answered, including phone calls. It is the Offeror’s responsibility to confirm receipt of all quotations and/or questions by the closing date of this announcement by contacting the above Contract Specialist/Contracting Officer.